Genprex, Inc.

Healthcare · Biotechnology · United States

Last price 2.24 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.84M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company’s technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes. Its oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company’s lead product candidate, Reqorsa Gene Therapy (quaratusugene ozeplasmid), is bei...